title: [Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis].
abstract: Intravenously administered immunoglobulins (IVIg) have been used for the treatment of various autoimmune diseases. In multiple sclerosis (MS), recent studies point out the beneficial role of this treatment that reduces relapse rate and arrests disease progression in relapsing-remitting patients. In the present article, we summarize and interpret the clinical, immunological, and neuro-radiological data related to IVIg treatment in MS. A synthesis between the information gathered will enable better understanding and treatment of this chronic disease.
authors.affiliation: Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israël.
authors.forename: A
authors.initials: A
authors.lastname: Achiron
authors.forename: S
authors.initials: S
authors.lastname: Miron
mesh_terms: D018450:Disease Progression; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000517:prevention & control; D012008:Recurrence
chemical_list: D016756:Immunoglobulins, Intravenous